Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Diagnostic Biomarkers Market Report 2025

Diagnostic Biomarkers Global Market Report 2025 - By Product (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Application (Oncology, Metabolic Disease, Neurological Disease), By End User (Hospitals, Cancer Research Institutes, Diagnostic Labs) - Market Size, Trends, And Global Forecast 2025-2034

Diagnostic Biomarkers Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Diagnostic Biomarkers Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Diagnostic Biomarkers Market

A diagnostic biomarker is a biological measure that assists in the diagnosis of a disease, helping to differentiate it from other conditions. It can encompass various findings, including laboratory results, radiological images, genetic markers, and physiological changes, and may also provide insights into disease progression and treatment efficacy.

The main types of products in diagnostic biomarkers are safety biomarkers, efficacy biomarkers, and validation biomarkers. Safety biomarkers are measurable indicators that assess the potential risk of toxicity or adverse effects associated with a medical treatment or environmental exposure and help determine whether a therapy is safe for patients by monitoring biological responses that may indicate harm. The applications include oncology, metabolic disease, and neurological disease for end users such as hospitals, cancer research institutes, and diagnostic labs.

How Is The Diagnostic Biomarkers Market Segmented?

The diagnostic biomarkers market covered in this report is segmented –

1) By Product: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Application: Oncology, Metabolic Disease, Neurological Disease

3) By End User: Hospitals, Cancer Research Institutes, Diagnostic Labs

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Organ-Specific Safety Biomarkers, Drug-Induced Injury Biomarkers

2) By Efficacy Biomarkers: Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers

3) By Validation Biomarkers: genomic biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers

Diagnostic Biomarkers Market Size and growth rate 2025 to 2029: Graph

What Is The Diagnostic Biomarkers Market Size 2025 And Growth Rate?

The diagnostic biomarkers market size has grown rapidly in recent years. It will grow from $65.25 billion in 2024 to $75.67 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, advancements in omics technologies, increasing demand for personalized medicine, growing awareness of early disease detection, and a surge in non-invasive diagnostic methods.

What Is The Diagnostic Biomarkers Market Growth Forecast?

The diagnostic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $136.57 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to growing adoption of liquid biopsy techniques, increasing investment in biomarker research, rising focus on precision medicine, and expanding applications in neurodegenerative diseases. Major trends in the forecast period include the advancements in artificial intelligence and machine learning, the integration of multi-omics approaches, the development of point-of-care diagnostic tools, the shift towards digital biomarkers, the growing use of wearable health monitoring devices, and the increasing emphasis on biomarker validation and standardization.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Diagnostic Biomarkers Market: Rising Cancer Incidence And Its Impact On Market

The growing prevalence of cancer drives the growth of the diagnostic biomarkers market going forward. The growing prevalence of cancer is driven by factors such as aging populations, lifestyle changes, environmental exposures, and improved diagnostic capabilities. Diagnostic biomarkers play a crucial role in cancer by enabling early detection, precise diagnosis, and personalized treatment strategies, improving patient outcomes. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 compared to 1,958,310 in 2023, reflecting a growth of 2.19%. The increasing prevalence of cancer is driving the growth of the diagnostic biomarkers market.

Who Are The Major Players In The Global Diagnostic Biomarkers Market?

Major companies operating in the diagnostic biomarkers market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS

What Are The Key Trends Of The Global Diagnostic Biomarkers Market: Advancing Non-Invasive Diagnostic Biomarkers For Early Disease Detection

Major companies in the diagnostic biomarkers market are focused on developing non-invasive testing methods, such as blood-based biomarker tests, to enhance patient comfort and accessibility with personalized treatment strategies. A blood-based biomarker test refers to a diagnostic tool that analyzes specific biological markers in the blood to detect or monitor diseases, such as Alzheimer's, in a minimally invasive manner. For instance, in July 2023, Quanterix Corporation, a US-based life sciences company, launched LucentAD, a blood-based biomarker test designed to assist healthcare providers in diagnosing Alzheimer's disease (AD) in patients exhibiting early cognitive symptoms. The test measures plasma levels of phosphorylated tau protein at the 181 residue (p-Tau 181), a biomarker associated with amyloid pathology in the brain, a key indicator of AD. By providing a less invasive and more accessible diagnostic tool compared to traditional methods like cerebrospinal fluid analysis or amyloid positron emission tomography, LucentAD aims to streamline the evaluation process for suspected Alzheimer's patients.

What Are Latest Mergers And Acquisitions In The Diagnostic Biomarkers Market: Trinity Biotech Acquires Metabolomics Diagnostics To Advance Biomarker-Based Diagnostic Solutions

In September 2024, Trinity Biotech, an Ireland-based clinical diagnostics company, acquired Metabolomics Diagnostics for approximately $1.3 million. This acquisition provides Trinity Biotech with a strategically valuable mass spectrometry platform integrated with machine learning-driven bioinformatics. Metabolomics Diagnostics is an Ireland-based company specializing in novel biomarker-based diagnostic solutions for complex diseases.

What Is The Regional Outlook For The Global Diagnostic Biomarkers Market?

North America was the largest region in the diagnostic biomarkers market in 2024. The regions covered in the diagnostic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diagnostic Biomarkers  Market?

The diagnostic biomarkers market consists of revenues earned by entities by providing services such as biomarker assay development and validation, biomarker-based diagnostic testing services, clinical trial support services, and data management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic biomarkers market also includes sales of biomarker assays, liquid biopsy kits, digital biomarkers, and genetic testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Diagnostic Biomarkers  Industry?

The diagnostic biomarkers market research report is one of a series of new reports from The Business Research Company that provides diagnostic biomarkers market statistics, including diagnostic biomarkers industry global market size, regional shares, competitors with a diagnostic biomarkers market share, detailed diagnostic biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic biomarkers industry. This diagnostic biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diagnostic Biomarkers Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $75.67 billion
Revenue Forecast In 2034 $136.57 billion
Growth Rate CAGR of 15.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The diagnostic biomarkers market covered in this report is segmented –
1) By Product: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Application: Oncology, Metabolic Disease, Neurological Disease
3) By End User: Hospitals, Cancer Research Institutes, Diagnostic Labs Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Organ-Specific Safety Biomarkers, Drug-Induced Injury Biomarkers
2) By Efficacy Biomarkers: Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers
3) By Validation Biomarkers: Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Diagnostic Biomarkers Market Characteristics

    3. Diagnostic Biomarkers Market Trends And Strategies

    4. Diagnostic Biomarkers Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Diagnostic Biomarkers Growth Analysis And Strategic Analysis Framework

    5.1. Global Diagnostic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Diagnostic Biomarkers Market Growth Rate Analysis

    5.4. Global Diagnostic Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Diagnostic Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Diagnostic Biomarkers Total Addressable Market (TAM)

    6. Diagnostic Biomarkers Market Segmentation

    6.1. Global Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Safety Biomarkers

    Efficacy Biomarkers

    Validation Biomarkers

    6.2. Global Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Metabolic Disease

    Neurological Disease

    6.3. Global Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Cancer Research Institutes

    Diagnostic Labs

    6.4. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Toxicity Biomarkers

    Organ-Specific Safety Biomarkers

    Drug-Induced Injury Biomarkers

    6.5. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Efficacy Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Predictive Biomarkers

    Prognostic Biomarkers

    Pharmacodynamic Biomarkers

    6.6. Global Diagnostic Biomarkers Market, Sub-Segmentation Of Validation Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Genomic Biomarkers

    Proteomic Biomarkers

    Metabolomic Biomarkers

    7. Diagnostic Biomarkers Market Regional And Country Analysis

    7.1. Global Diagnostic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Diagnostic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Diagnostic Biomarkers Market

    8.1. Asia-Pacific Diagnostic Biomarkers Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Diagnostic Biomarkers Market

    9.1. China Diagnostic Biomarkers Market Overview

    9.2. China Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Diagnostic Biomarkers Market

    10.1. India Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Diagnostic Biomarkers Market

    11.1. Japan Diagnostic Biomarkers Market Overview

    11.2. Japan Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Diagnostic Biomarkers Market

    12.1. Australia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Diagnostic Biomarkers Market

    13.1. Indonesia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Diagnostic Biomarkers Market

    14.1. South Korea Diagnostic Biomarkers Market Overview

    14.2. South Korea Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Diagnostic Biomarkers Market

    15.1. Western Europe Diagnostic Biomarkers Market Overview

    15.2. Western Europe Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Diagnostic Biomarkers Market

    16.1. UK Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Diagnostic Biomarkers Market

    17.1. Germany Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Diagnostic Biomarkers Market

    18.1. France Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Diagnostic Biomarkers Market

    19.1. Italy Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Diagnostic Biomarkers Market

    20.1. Spain Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Diagnostic Biomarkers Market

    21.1. Eastern Europe Diagnostic Biomarkers Market Overview

    21.2. Eastern Europe Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Diagnostic Biomarkers Market

    22.1. Russia Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Diagnostic Biomarkers Market

    23.1. North America Diagnostic Biomarkers Market Overview

    23.2. North America Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Diagnostic Biomarkers Market

    24.1. USA Diagnostic Biomarkers Market Overview

    24.2. USA Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Diagnostic Biomarkers Market

    25.1. Canada Diagnostic Biomarkers Market Overview

    25.2. Canada Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Diagnostic Biomarkers Market

    26.1. South America Diagnostic Biomarkers Market Overview

    26.2. South America Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Diagnostic Biomarkers Market

    27.1. Brazil Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Diagnostic Biomarkers Market

    28.1. Middle East Diagnostic Biomarkers Market Overview

    28.2. Middle East Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Diagnostic Biomarkers Market

    29.1. Africa Diagnostic Biomarkers Market Overview

    29.2. Africa Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Diagnostic Biomarkers Market Competitive Landscape And Company Profiles

    30.1. Diagnostic Biomarkers Market Competitive Landscape

    30.2. Diagnostic Biomarkers Market Company Profiles

    30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Diagnostic Biomarkers Market Other Major And Innovative Companies

    31.1. Siemens Healthineers AG

    31.2. Merck KGaA

    31.3. Agilent Technologies Inc.

    31.4. Charles River Laboratories International Inc.

    31.5. Bio-Rad Laboratories Inc.

    31.6. Bruker Corporation

    31.7. Qiagen N.V.

    31.8. Myriad Genetics Inc.

    31.9. Meso Scale Diagnostics LLC

    31.10. EKF Diagnostics Holdings Plc

    31.11. Sino Biological Inc.

    31.12. Enzo Biochem Inc.

    31.13. Biomarker Technologies Inc.

    31.14. Cisbio Bioassays

    31.15. Signosis Inc.

    32. Global Diagnostic Biomarkers Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Diagnostic Biomarkers Market

    34. Recent Developments In The Diagnostic Biomarkers Market

    35. Diagnostic Biomarkers Market High Potential Countries, Segments and Strategies

    35.1 Diagnostic Biomarkers Market In 2029 - Countries Offering Most New Opportunities

    35.2 Diagnostic Biomarkers Market In 2029 - Segments Offering Most New Opportunities

    35.3 Diagnostic Biomarkers Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Efficacy Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Validation Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Diagnostic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Diagnostic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Johnson & Johnson Services Inc. Financial Performance
  • Table 78: F. Hoffmann-La Roche AG Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: PerkinElmer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Efficacy Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Diagnostic Biomarkers Market, Sub-Segmentation Of Validation Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Diagnostic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Diagnostic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Diagnostic Biomarkers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Diagnostic Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Diagnostic Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Johnson & Johnson Services Inc. Financial Performance
  • Figure 78: F. Hoffmann-La Roche AG Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: PerkinElmer Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

Biomarkers Global Market Report 2025 – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases), By Type (Biomarker Of Exposure, Biomarker Of Diseases), By Audiences (Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies), By Application (Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025 – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Disease (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End Use (Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Testing Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types), By Location Of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications), By End User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Biomarkers Global Market Report 2025 – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications), By End-User (Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Central Nervous System Biomarkers Global Market Report 2025 – By Type (Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types), By Disease (Multiple Sclerosis, Alzheimer's Disease, Parkinson's Disease, Traumatic Brain Injury, Other Diseases), By Application (Drug Discovery And Development, Personalized Medicines, Disease Risk Assessment, Diagnostics, Other Applications), By End-Users (Diagnostic Labs, Clinics, Hospitals, Research Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Clinical Biomarkers Global Market Report 2025 – By Offering (Product, Service), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas), By Application (Clinical Diagnostic, Translational Research), By End User (Contract Research Organizations (CROs), Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Diagnostic Biomarkers market?

A diagnostic biomarker is a biological measure that assists in the diagnosis of a disease, helping to differentiate it from other conditions. It can encompass various findings, including laboratory results, radiological images, genetic markers, and physiological changes, and may also provide insights into disease progression and treatment efficacy. For further insights on the Diagnostic Biomarkers market, request a sample here

How will the Diagnostic Biomarkers market drivers and restraints affect the market dynamics? What forces will shape the Diagnostic Biomarkers industry going forward?

The Diagnostic Biomarkers market major growth driver - Rising Cancer Incidence And Its Impact On Market. For further insights on the Diagnostic Biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the Diagnostic Biomarkers market?

The Diagnostic Biomarkers market size has grown strongly in recent years. The diagnostic biomarkers market size has grown rapidly in recent years. It will grow from $65.25 billion in 2024 to $75.67 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, advancements in omics technologies, increasing demand for personalized medicine, growing awareness of early disease detection, and a surge in non-invasive diagnostic methods. The diagnostic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $136.57 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to growing adoption of liquid biopsy techniques, increasing investment in biomarker research, rising focus on precision medicine, and expanding applications in neurodegenerative diseases. Major trends in the forecast period include the advancements in artificial intelligence and machine learning, the integration of multi-omics approaches, the development of point-of-care diagnostic tools, the shift towards digital biomarkers, the growing use of wearable health monitoring devices, and the increasing emphasis on biomarker validation and standardization. For further insights on the Diagnostic Biomarkers market, request a sample here

How is the Diagnostic Biomarkers market segmented?

The diagnostic biomarkers market covered in this report is segmented –
1) By Product: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Application: Oncology, Metabolic Disease, Neurological Disease
3) By End User: Hospitals, Cancer Research Institutes, Diagnostic Labs

Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Organ-Specific Safety Biomarkers, Drug-Induced Injury Biomarkers
2) By Efficacy Biomarkers: Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers
3) By Validation Biomarkers: Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers For further insights on the Diagnostic Biomarkers market, request a sample here

Which region has the largest share of the Diagnostic Biomarkers market? What are the other regions covered in the report?

North America was the largest region in the diagnostic biomarkers market in 2024. The regions covered in the diagnostic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Diagnostic Biomarkers market, request a sample here.

Who are the major players in the Diagnostic Biomarkers market?

Major companies operating in the diagnostic biomarkers market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS . For further insights on the Diagnostic Biomarkers market, request a sample here.

What are the key trends in the Diagnostic Biomarkers market?

Major trends in the Diagnostic Biomarkers market include Advancing Non-Invasive Diagnostic Biomarkers For Early Disease Detection. For further insights on the Diagnostic Biomarkers market, request a sample here.

What are the major opportunities in the Diagnostic Biomarkers market? What are the strategies for the Diagnostic Biomarkers market?

For detailed insights on the major opportunities and strategies in the Diagnostic Biomarkers market, request a sample here.

How does the Diagnostic Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Diagnostic Biomarkers market growth and SWOT analysis of the Diagnostic Biomarkers industry, request a sample here.

For detailed insights on Diagnostic Biomarkers's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Diagnostic Biomarkers industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Diagnostic Biomarkers industry,

What are the key dynamics influencing the Diagnostic Biomarkers market growth? SWOT analysis of the Diagnostic Biomarkers market. request a sample here.